Following the news from Africa

Provided by AGP

Times Reporter of Africa
Got News to Share?
Got News to Share? Explore more publications!

Times Reporter of Africa: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Times Reporter of Africa.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 6, 2026

OR Royalties Declares 18% Increase to Quarterly Dividend
May. 6, 2026

OR Royalties Declares 18% Increase to Quarterly Dividend

Indeterminate GlobeNewswire
Redevances OR déclare une augmentation de 18 % du dividende trimestriel
May. 6, 2026

Redevances OR déclare une augmentation de 18 % du dividende trimestriel

Indeterminate GlobeNewswire
Lesaka’s Q3 FY2026 Results: Lesaka achieves the upper end of profitability guidance and raises its FY2026 full year Adjusted Earnings per Share guidance
May. 6, 2026

Lesaka’s Q3 FY2026 Results: Lesaka achieves the upper end of profitability guidance and raises its FY2026 full year Adjusted Earnings per Share guidance

Indeterminate GlobeNewswire
OR Royalties Reports 56% Year-Over-Year Increase in Cash Flows from Operations in Q1 2026
May. 6, 2026

OR Royalties Reports 56% Year-Over-Year Increase in Cash Flows from Operations in Q1 2026

Indeterminate GlobeNewswire
Redevances OR annonce une hausse de 56 %, d’une année sur l’autre, des flux de trésorerie générés par les activités d'exploitation au premier trimestre 2026
May. 6, 2026

Redevances OR annonce une hausse de 56 %, d’une année sur l’autre, des flux de trésorerie générés par les activités d'exploitation au premier trimestre 2026

Indeterminate GlobeNewswire
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026
May. 6, 2026

Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026

Indeterminate GlobeNewswire
Tenaya Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May. 6, 2026

Tenaya Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress
May. 6, 2026

Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress

Indeterminate GlobeNewswire
BridgeBio to Participate in May and June Investor Conferences
May. 6, 2026

BridgeBio to Participate in May and June Investor Conferences

Indeterminate GlobeNewswire
Hercules Metals Increases Previously Announced Bought Deal Financing and Concurrent Private Placement to C$31.5 Million
May. 6, 2026

Hercules Metals Increases Previously Announced Bought Deal Financing and Concurrent Private Placement to C$31.5 Million

Indeterminate GlobeNewswire
BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle
May. 6, 2026

BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle

Indeterminate GlobeNewswire
Where Executives Are Doubling Down on Their Companies’ Fortunes
May. 6, 2026

Where Executives Are Doubling Down on Their Companies’ Fortunes

Indeterminate GlobeNewswire
Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th
May. 6, 2026

Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th

Indeterminate GlobeNewswire
Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
May. 6, 2026

Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update

Indeterminate GlobeNewswire
Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease
May. 6, 2026

Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease

Indeterminate GlobeNewswire
InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares
May. 6, 2026

InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares

Indeterminate GlobeNewswire
InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases
May. 6, 2026

InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases

Indeterminate GlobeNewswire
Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
May. 6, 2026

Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement

Indeterminate GlobeNewswire
Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026
May. 6, 2026

Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference
May. 6, 2026

Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn

Sign up for:

Times Reporter of Africa

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.